141 related articles for article (PubMed ID: 10582347)
1. The stem cell leukaemia (SCL) gene: a critical regulator of haemopoietic and vascular development.
Barton LM; Göttgens B; Green AR
Int J Biochem Cell Biol; 1999 Oct; 31(10):1193-207. PubMed ID: 10582347
[No Abstract] [Full Text] [Related]
2. The SCL gene: from case report to critical hematopoietic regulator.
Begley CG; Green AR
Blood; 1999 May; 93(9):2760-70. PubMed ID: 10216069
[No Abstract] [Full Text] [Related]
3. T-cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCL/tal.
Goldfarb AN; Greenberg JM
Leuk Lymphoma; 1994 Jan; 12(3-4):157-66. PubMed ID: 8167548
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cellular differentiation by the SCL/tal oncoprotein: transcriptional repression by an Id-like mechanism.
Goldfarb AN; Lewandowska K
Blood; 1995 Jan; 85(2):465-71. PubMed ID: 7812000
[TBL] [Abstract][Full Text] [Related]
5. The helix-loop-helix gene SCL: implicated in T-cell acute lymphoblastic leukaemia and in normal haematopoietic development.
Robb L; Begley CG
Int J Biochem Cell Biol; 1996 Jun; 28(6):609-18. PubMed ID: 8673726
[TBL] [Abstract][Full Text] [Related]
6. Transcription factors of the bHLH and LIM families: synergistic mediators of T cell acute leukemia?
Baer R; Hwang LY; Bash RO
Curr Top Microbiol Immunol; 1997; 220():55-65. PubMed ID: 9103675
[No Abstract] [Full Text] [Related]
7. Nuclear localization of the SCL/TAL1 basic helix-loop-helix protein is not dependent on the presence of the basic domain.
Bernard M; Smit L; Macintyre E; Matthieu-Mahul D; Pulford K
Blood; 1995 Jun; 85(11):3356-7. PubMed ID: 7756670
[No Abstract] [Full Text] [Related]
8. SCL: from the origin of hematopoiesis to stem cells and leukemia.
Lécuyer E; Hoang T
Exp Hematol; 2004 Jan; 32(1):11-24. PubMed ID: 14725896
[TBL] [Abstract][Full Text] [Related]
9. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
10. Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding.
Porcher C; Liao EC; Fujiwara Y; Zon LI; Orkin SH
Development; 1999 Oct; 126(20):4603-15. PubMed ID: 10498694
[TBL] [Abstract][Full Text] [Related]
11. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
Curry JD; Smith MT
Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
[TBL] [Abstract][Full Text] [Related]
12. Absence of SCL mutations in myeloid malignancies.
Delabesse E; Li J; Schnittger S; Hiddemann W; Green AR
Br J Haematol; 2003 Feb; 120(3):482-3. PubMed ID: 12580964
[TBL] [Abstract][Full Text] [Related]
13. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
Robb L; Begley CG
Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
[TBL] [Abstract][Full Text] [Related]
14. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
Hsu HL; Wadman I; Tsan JT; Baer R
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the stem cell leukemia gene (SCL)--comparative analysis of five vertebrate SCL loci.
Göttgens B; Barton LM; Chapman MA; Sinclair AM; Knudsen B; Grafham D; Gilbert JG; Rogers J; Bentley DR; Green AR
Genome Res; 2002 May; 12(5):749-59. PubMed ID: 11997341
[TBL] [Abstract][Full Text] [Related]
16. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.
Göttgens B; Broccardo C; Sanchez MJ; Deveaux S; Murphy G; Göthert JR; Kotsopoulou E; Kinston S; Delaney L; Piltz S; Barton LM; Knezevic K; Erber WN; Begley CG; Frampton J; Green AR
Mol Cell Biol; 2004 Mar; 24(5):1870-83. PubMed ID: 14966269
[TBL] [Abstract][Full Text] [Related]
17. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.
Aplan PD; Lombardi DP; Reaman GH; Sather HN; Hammond GD; Kirsch IR
Blood; 1992 Mar; 79(5):1327-33. PubMed ID: 1311214
[TBL] [Abstract][Full Text] [Related]
19. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
O'Neil J; Billa M; Oikemus S; Kelliher M
Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
[TBL] [Abstract][Full Text] [Related]
20. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
